Search - tctmd.com

Displaying 541 - 560 of 696

Sort: Relevancy | Date

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

La Última Frontera: Válvulas Reposicionables, Recuperables y Transcatéter en el Manejo de la Regurgitación Aórtica No Calcificada

Yael L. Maxwell

November 24, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

Presentation TCT 2015

New Randomized Trial Data (1-Year Outcomes): ABSORB China (TCT Late-Breaking Clinical Trial Results and Beyond)

Presenter: Stephen G. Ellis, Patrick W. Serruys, Run-Lin Gao

October 14, 2015

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Ioanna Kosmidou, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

Presentation TCT 2015

Use of Appropriate CTO Techniques: Chinese Perspectives

Presenter: Run-Lin Gao, Dimitri Karmpaliotis, Bo Xu, Jiyan Chen

October 11, 2015

Presentation TCT 2015

How Did I Treat a Patient With a Severe Calcified Chronic Total Occlusion?

Presenter: Run-Lin Gao, Dimitri Karmpaliotis, Bo Xu, Lei Ge

October 11, 2015

Presentation TCT 2015

How Would I Treat a Patient With a Severe Calcified Chronic Total Occlusion?

Presenter: Run-Lin Gao, Dimitri Karmpaliotis, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

How Should I Treat a Patient With a Severe Calcified Chronic Total Occlusion?

Presenter: Run-Lin Gao, Dimitri Karmpaliotis, Bo Xu, Lei Ge

October 11, 2015

Presentation TCT 2015

Development of TAVR in China: Clinical Data and Experience

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yuejin Yang

October 11, 2015

Presentation TCT 2015

How Did I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yongjian Wu

October 11, 2015

Presentation TCT 2015

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Mao Chen

October 11, 2015

Advertisement

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

La Última Frontera: Válvulas Reposicionables, Recuperables y Transcatéter en el Manejo de la Regurgitación Aórtica No Calcificada

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

My Takeaways From TCT 2015

New Randomized Trial Data (1-Year Outcomes): ABSORB China (TCT Late-Breaking Clinical Trial Results and Beyond)

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

Absorb BVS Matches Xience V in Chinese Patients

Use of Appropriate CTO Techniques: Chinese Perspectives

How Did I Treat a Patient With a Severe Calcified Chronic Total Occlusion?

How Would I Treat a Patient With a Severe Calcified Chronic Total Occlusion?

How Should I Treat a Patient With a Severe Calcified Chronic Total Occlusion?

Development of TAVR in China: Clinical Data and Experience

How Did I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content